This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Screening Protocol for Research Participants (ScreenProt)

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2017 by MPRC, University of Maryland
Information provided by (Responsible Party):
MPRC, University of Maryland Identifier:
First received: July 8, 2009
Last updated: May 15, 2017
Last verified: May 2017
The Screening Protocol is a system devised to evaluate potential research participants for National Institute on Drug Abuse/Maryland Psychiatric Research Center (NIDA/MPRC) studies.

Condition Intervention
Schizophrenia Substance Abuse Cocaine Abuse Tobacco Use Disorder Behavioral: Various Screening psychiatric and medical assessments

Study Type: Observational
Study Design: Observational Model: Other
Time Perspective: Prospective
Official Title: Screening Protocol for the Evaluation of Research Participants

Resource links provided by NLM:

Further study details as provided by MPRC, University of Maryland:

Primary Outcome Measures:
  • Recruitment of participants into NIDA/MPRC protocols. [ Time Frame: 5 years ]

Secondary Outcome Measures:
  • Demographic characterization of drug users, non-users, and individuals with serious mental illnesses contacting NIDA/MPRC about research participation [ Time Frame: 5 year ]

Estimated Enrollment: 5000
Study Start Date: December 2009
Estimated Study Completion Date: March 2025
Estimated Primary Completion Date: March 2020 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Screening Assessment battery. Specific to study(or studies) the individual is screening for.
Behavioral: Various Screening psychiatric and medical assessments
Possibly blood draws, urine samples, toxicology screens, computer-based and written psychological, psychiatric, and behavioral questionnaires and assessments.

Detailed Description:

The MPRC/NIDA collaborative research program attempts to: elucidate the nature of serious mental illnesses, drug abuse and addiction; determine the potential use of new therapies, both pharmacological and psychosocial; and decipher the long-term effects of drugs of abuse on the development, maturation, function, and structure of the brain and other organ systems. In support of this work, the scientific goal of this screening protocol is to assess potential research participants' eligibility for research studies. Screening will include medical and psychological tests and procedures. The data collected during screening are a unique and valuable source of information that aids in the research mission. Therefore, a secondary goal of this protocol is to obtain data that characterizes the population of subjects contacting NIDA about research participation and to analyze data so obtained, such as that on the prevalence and consequences of HIV/AIDS, viral hepatitis, and related diseases and issues of selection and sample bias in clinical research.

The screening process will be done in two stages, a telephone interview and an in-person evaluation. The telephone interview will last approximately 20 minutes and be conducted solely via the NIDA call center. Answers provided during the phone interview will indicate whether a caller is eligible for in-person screening. Those who appear eligible will be given an appointment at either NIDA or MPRC. This protocol pertains only to the in-person participants at MPRC. Written informed consent will be obtained when the person arrives. The screening process can involve up to 5 visits to MPRC.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Population will see an advertisement in the community and call the NIDA call center. If they appear to meet the qualifications for one or more NIDA/MPRC studies, they will be scheduled to be screened.

Inclusion Criteria:

  • Age 18 or older
  • Ability to read and understand and answer questions posed.

Exclusion Criteria:

  • Inability to provide valid informed consent
  • Below Age 18, and above age 64.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01010620

Contact: Christopher Kitchen 410-402-6425

United States, Maryland
Maryland Psychiatric Research Center Recruiting
Catonsville, Maryland, United States, 21228
Contact: Christopher Kitchen    410-402-6425   
Contact: Stephanie Feldman, LCSW-C    410-402-6885   
Principal Investigator: Deanna L Kelly, Pharm.D., BCPP         
Sponsors and Collaborators
University of Maryland
Principal Investigator: Deanna L Kelly, Pharm.D., BCPP University of Maryland
  More Information

Additional Information:
Responsible Party: MPRC, Kimberly Warren, PhD, University of Maryland Identifier: NCT01010620     History of Changes
Other Study ID Numbers: HP-00043664
MPRC #412
NIDA #444
Study First Received: July 8, 2009
Last Updated: May 15, 2017

Keywords provided by MPRC, University of Maryland:
research participation
substance abuse

Additional relevant MeSH terms:
Substance-Related Disorders
Tobacco Use Disorder
Cocaine-Related Disorders
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders
Chemically-Induced Disorders processed this record on September 25, 2017